Rapid weight loss and reduced nutrient intake may lead to some bone density reduction
For Weight Management Certain treatments can help with weight, as they are approved for chronic weight management in individuals who are overweight
Simultaneously, its glucagon receptor agonism supports hepatic glucose output (gluconeogenesis), helping maintain blood glucose within a stable range
GLP-1 drugs will continue to be available for other purposes, such as managing Type 2 diabetes, through Part D plans
By week 16 to 20 At the four to five month mark, total weight loss from baseline typically ranges from 8 to 15 percent of starting body weight
However, the metabolic advantages (improved insulin sensitivity, enhanced fat oxidation) will diminish over time without continued use